|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / uUvhDrgUNkChf |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Adolfo Гость |
Добавлено: 10-08-2021 16:30 |
|
Could you ask her to call me? viagros Patients taking the drug, called alirocumab, had their cholesterol reduced by an average of 47% over nearly six months, compared with a 16% decline in patients receiving ezetimibe, a drug marketed as Zetia by Merck & Co. (MRK). The study included 103 patients with moderate cardiovascular risk who weren't recommended by their physicians to take statins, the most effective and commonly used cholesterol-lowering treatments now on the market. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / uUvhDrgUNkChf |